We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Saliva Test Detects Alcohol Exposure

By LabMedica International staff writers
Posted on 25 Aug 2010
An innovative analytical test is capable of detecting Ethyl Sulfate (EtS) and Ethyl Glucuronide (EtG), produced by the body after alcohol exposure, in a simple saliva sample.

The Saliva-Alcohol Alco-Screen test is intended for use as a rapid, highly sensitive method to detect the presence of alcohol in saliva to provide an approximation of relative blood alcohol concentration, allowing for greater detection sensitivity than breath testing methods. The simple, one-step, two-minute test requires no instrumentation, calibration, or special training to be used effectively. For applications where a qualitative determination of blood alcohol concentration is required for forensic purposes, liquid chromatography-mass spectrometry-mass spectrometry (LC/MS/MS) technology is used for confirmation of the oral fluid test result.

Since the relationship between the amount of saliva alcohol and blood alcohol is 1:1, while with breath it is 0.000048:1, saliva serves as a more sensitive testing medium than breath. Another advantage of saliva analysis is ease of collection, since the sample is produced with direct observation that is not gender dependent (such as a urine test), and the oral fluid collector can be easily labeled and secured in a strict chain of custody procedures. Oral fluid samples also provide a good indication of recent drug use, as most drugs are present in the saliva for 2-4 days after use. The Saliva-Alcohol Alco-Screen test is a product of Forensic Laboratories (Denver, CO, USA).

"Our mass spectrometry division was one of the first to offer the quantitation of both EtG and EtS in urine,” said James Ruth, Ph.D., Forensic Laboratories' laboratory director. "Now we are the first to offer EtS in oral fluid.”

Both EtG and EtS are minor but important metabolites of alcohol, because they are more slowly eliminated from the body than alcohol itself and can thus be used to better document and detect alcohol. Both EtG and EtS have similar time spectra; one standard drink, in an average person, can be detectable for about 24 hours (using the lowest cutoffs of 100 ng/ml for EtG and 25 ng/ml for EtS), whereas urine alcohol will disappear following one drink within about 4 to 6 hours; after binge drinking EtG and/or EtS can be detected in urine for several days or more. However, while EtG is degraded in urine when certain bacteria are present (which can cause a false negative test), EtS has not been shown to be degraded by bacteria.

Related Links:

Forensic Laboratories



Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Biological Indicator Vials
BI-O.K.
New
Silver Member
Total Hemoglobin Monitoring System
GREENCARE Hb
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The UV absorbance spectrometer being used to measure the absorbance spectra of cell culture samples (Photo courtesy of SMART CAMP)

Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures

Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.